DNPEP | Aspartyl aminopeptidase | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
DPEP1 | Dipeptidase 1 (renal) | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
DPP3 | Dipeptidyl-peptidase 3 | Enzymes Plasma proteins
| | | | | Expressed in all |
DPP7 | Dipeptidyl-peptidase 7 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
DPP8 | Dipeptidyl-peptidase 8 | Enzymes Plasma proteins
| | | | | Expressed in all |
DPP9 | Dipeptidyl-peptidase 9 | Enzymes
| | | | | Expressed in all |
DUSP10 | Dual specificity phosphatase 10 | Enzymes
| | | | | Expressed in all |
DUSP16 | Dual specificity phosphatase 16 | Enzymes
| | | | | Expressed in all |
DUSP18 | Dual specificity phosphatase 18 | Enzymes
| | | | | Mixed |
DUSP3 | Dual specificity phosphatase 3 | Enzymes Plasma proteins
| | | | | Expressed in all |
DUSP4 | Dual specificity phosphatase 4 | Cancer-related genes Enzymes Plasma proteins
| | | | | Tissue enhanced |
DUT | Deoxyuridine triphosphatase | Enzymes Mitochondrial proteins
| | | | | Expressed in all |
EIF4A3 | Eukaryotic translation initiation factor 4A3 | Disease related genes Enzymes Plasma proteins Potential drug targets Transporters
| | | | | Expressed in all |
ELAC2 | ElaC ribonuclease Z 2 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
ENOPH1 | Enolase-phosphatase 1 | Enzymes
| | | | | Expressed in all |
ENTPD4 | Ectonucleoside triphosphate diphosphohydrolase 4 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
EPHX2 | Epoxide hydrolase 2, cytoplasmic | Enzymes Plasma proteins
| | | | | Expressed in all |
ERCC2 | Excision repair cross-complementing rodent repair deficiency, complementation group 2 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ERCC3 | Excision repair cross-complementing rodent repair deficiency, complementation group 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
ERCC6L | Excision repair cross-complementing rodent repair deficiency, complementation group 6-like | Enzymes
| | | | | Mixed |
ESD | Esterase D | Enzymes Plasma proteins
| | | | | Expressed in all |
ESPL1 | Extra spindle pole bodies homolog 1 (S. cerevisiae) | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
EYA2 | Eyes absent homolog 2 (Drosophila) | Enzymes Plasma proteins
| | | | | Tissue enhanced |
EYA3 | Eyes absent homolog 3 (Drosophila) | Enzymes
| | | | | Expressed in all |
FAHD1 | Fumarylacetoacetate hydrolase domain containing 1 | Enzymes
| | | | | Expressed in all |
FAN1 | FANCD2/FANCI-associated nuclease 1 | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
FANCM | Fanconi anemia, complementation group M | Disease related genes Enzymes Potential drug targets
| | | | | Mixed |
FASN | Fatty acid synthase | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
FURIN | Furin (paired basic amino acid cleaving enzyme) | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
G3BP1 | GTPase activating protein (SH3 domain) binding protein 1 | Enzymes Plasma proteins
| | | | | Expressed in all |
GANAB | Glucosidase, alpha; neutral AB | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
GCH1 | GTP cyclohydrolase 1 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
GLB1 | Galactosidase, beta 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
GNE | Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
GTF2F2 | General transcription factor IIF, polypeptide 2, 30kDa | Enzymes
| | | | | Expressed in all |
GUSB | Glucuronidase, beta | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
GZMB | Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
HDAC1 | Histone deacetylase 1 | Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
HDAC2 | Histone deacetylase 2 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
HDAC3 | Histone deacetylase 3 | Enzymes FDA approved drug targets
| | | | | Expressed in all |
HDAC4 | Histone deacetylase 4 | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
HDAC5 | Histone deacetylase 5 | Cancer-related genes Enzymes
| | | | | Expressed in all |
HDAC6 | Histone deacetylase 6 | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Expressed in all |
HDAC7 | Histone deacetylase 7 | Enzymes Plasma proteins
| | | | | Expressed in all |
HDAC8 | Histone deacetylase 8 | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
HELQ | Helicase, POLQ-like | Enzymes
| | | | | Expressed in all |
HFM1 | HFM1, ATP-dependent DNA helicase homolog (S. cerevisiae) | Enzymes
| | | | | Tissue enhanced |
HPSE | Heparanase | Enzymes Predicted secreted proteins
| | | | | Mixed |
HYAL3 | Hyaluronoglucosaminidase 3 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
ICT1 | Immature colon carcinoma transcript 1 | Enzymes
| | | | | Expressed in all |